Analysis of the data from the open-label pivotal trial of oxylanthanum carbonate (OLC) highlights that pill burden was significantly reduced in terms of both pill volume (7x) and pill count (2x) from ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the ...

My experiences have demonstrated that business development combined with market analysis is the most powerful pairing for ...

Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...

Simplify Excel file sharing and exporting. Learn how to collaborate in the cloud, email files, and manage formats with ease.

CHICAGO -- Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in ...

GLP-1 receptor agonists may have beneficial effects against Alzheimers, psychiatric and addiction disorders, but early data ...

MASH data to be presented at the 76th Annual AASLD The Liver Meeting®, 7-11 November Highlights include data from post-hoc analyses ...

VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of pathogenic IgGs in disease activityFinal ADAPT SC+ results show ...

Antidepressants show clinically significant and highly heterogeneous effects on cardiometabolic parameters, weight, and blood ...

American Critical Minerals has voluntarily filed a National Instrument 43-101 Technical Report supporting the exploration targets for Potash, Lithium and Bromine. 2.1 billion cubic meters (brine ...

If you’ve ever wished you could catch a stock’s move before it takes off, veteran trader Thomas Wood’s MQ Momentum Indicator might be what you’ve been ...